Trastuzumab Terminated Phase 1 Trials for Her2-Positive Breast Cancer / Male Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00039455Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer